Association between sarcopenia and history of fractures in elderly patients with type 2 diabetes

Authors

DOI:

https://doi.org/10.11606/issn.2176-7262.v53i4p389-397

Keywords:

Sarcopenia, Diabetes Mellitus, Fractures, Bone

Abstract

Objective: Evaluating the prevalence of sarcopenia in elderly patients with diabetes mellitus (DM), verifying their association with a history of fractures and falls. Study model: Observational, cross-sectional, and analytical. Method: The study was conducted at a university hospital in Campina Grande, Paraíba. It included elderly patients (≥60 years) with DM. Those with a diagnosis of osteoporosis were excluded. The predictor criterion for sarcopenia was calf circumference (CC): <33 cm for women and <34 cm for men. Results: The valid sample was 44 patients, all with type 2 diabetes mellitus (DM2). The prevalence of sarcopenia was 20.4%. There was a statistically significant relationship between sarcopenia and history of fractures in low energy traumas (p=0.022). There was no difference between the groups with and without sarcopenia in relation to the history of falls in the last year (p=0.589). There was an association between the use of psychotropic drugs and the occurrence of falls (p=0.001). Most of the findings converged with those already present in the literature.  Conclusion: Although CC is not an established method for the diagnosis of sarcopenia, muscle loss indicated by this measure has been associated with a history of fractures in the elderly with DM2, so that this accessible measurement can alert to initiate interventions that can improve the quality of life of the elderly.

Downloads

Download data is not yet available.

References

World Health Organization. Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity. Geneva; 2017. Disponível em: https://apps.who.int/iris/bitstream/handle/10665/258981/9789241550109-eng.pdf.

Miranda GMD, Mendes ACG, Silva ALA. O envelhecimento populacional brasileiro: desafios e consequências sociais atuais e futuras. Rev. bras. geriatr. gerontol. 2016;19(3):507-19. doi: http://dx.doi.org/10.1590/1809-98232016019.150140.

Moraes EN. Atenção à saúde do idoso: aspectos conceituais. Brasília: Organização Pan-Americana da Saúde; 2012. Disponível em: https://apsredes.org/pdf/Saude-do-Idoso-WEB1.pdf.

Oliveira B, Concone MHVB, Lodovici FMM, Lopes RGC, Côrte R. Quem cuidará de nós em 2030? Prospecção e consenso na região metropolitana de São Paulo. Estud. interdiscipl. envelhec. 2016;21(1):11-34. Disponível em: https://seer.ufrgs.br/RevEnvelhecer/article/view/49469/40710.

Yang R, Zhang Y, Shen X, Yan S. Sarcopenia associated with renal function in the patients with type 2 diabetes. Diabetes Res Clin Pract. 2016;118:121-9. doi: https://doi.org/10.1016/j.diabres.2016.06.023

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-23. doi: https://doi.org/10.1093/ageing/afq034.

Rosenberg IH. Sarcopenia: Origins and Clinical Relevance. J Nutr. 1997; 127(Supl 7):990S-991S. doi: https://doi.org/10.1093/jn/127.5.990S.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi: 10.1093/ageing/afy169.

Guglielmi G, Ponti F, Agostini M, Amadori M, Battista G, Bazzocchi A. The role of DXA in sarcopenia. Aging Clin Exp Res. 2016;28(6):1047-60. doi: https://doi.org/10.1007/s40520-016-0589-3.

Pagotto V, Santos KFD, Malaquias SG, Bachion MM, Silveira EA. Calf circumference: clinical validation for evaluation of muscle mass in the elderly. Rev Bras Enferm. 2018;71(2):322-8. doi: https://doi.org/10.1590/0034-7167-2017-0121.

Barbosa-Silva TG, Bielemann RM, Gonzalez MC, Menezes AM. Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of the COMO VAI? study. J Cachexia Sarcopenia Muscle. 2016;7(2):136-43. doi: https://doi.org/10.1002/jcsm.12049.

Kramer IF, Snijders T, Smeets JSJ, Leenders M, van Kranenburg J, den Hoed M, et al. Extensive Type II Muscle Fiber Atrophy in Elderly Female Hip Fracture Patients. J Gerontol A Biol Sci Med Sci. 2017;72(10):1369-75. doi: https://doi.org/10.1093/gerona/glw253.

Fabrício SCC, Rodrigues RAP, Costa Junior ML. Causas e conseqüências de quedas de idosos atendidos em hospital público. Rev Saude Publica. 2004;38(1):93-99. doi: http://dx.doi.org/10.1590/S0034-89102004000100013.

Bortolon PC, Andrade CLT, Andrade CAF. O perfil das internações do SUS para fratura osteoporótica de fêmur em idosos no Brasil: uma descrição do triênio 2006-2008. Cad Saude Publica. 2011;27(4):733-42. doi: http://dx.doi.org/10.1590/S0102-311X2011000400012.

Stolnicki B, Oliveira LG. Para que a primeira fratura seja a última. Rev Bras Ortop. 2016;51(2):121-26. doi: https://doi.org/10.1016/j.rboe.2016.01.005.

Pérez-López FR, Ara I. Fragility fracture risk and skeletal muscle function. Climacteric. 2016;19(1):37-41. doi: https://doi.org/10.3109/13697137.2015.1115261.

Moon SS. Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2010. Endocr J. 2014;61(1):61-70. doi: https://doi.org/10.1507/endocrj.EJ13-0244.

Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819-29. doi: https://dx.doi.org/10.1016%2FS2213-8587(14)70034-8.

He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng HW. Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int. 2016;27(2):473-82. doi: https://doi.org/10.1007/s00198-015-3241-8.

Yu R, Leung J, Woo J. Incremental predictive value of sarcopenia for incident fracture in an elderly Chinese cohort: results from the Osteoporotic Fractures in Men (MrOs) Study. J Am Med Dir Assoc. 2014;15(8):551-8. doi: https://doi.org/10.1016/j.jamda.2014.02.005.

Lipschitz DA. Screening for nutritional status in the elderly. Prim Care. 1944;21(1):55-67.

Santos ADA, Pinho CPS, Nascimento ACS, Costa ACO. Sarcopenia in elderly outpatients: prevalence and associated factors. Nutr Hosp. 2016;33(2):255-62.

Montero-Fernández N, Serra-Rexach JA. Role of exercise on sarcopenia in the elderly. Eur J Phys Rehabil Med. 2013:49(1):131-43.

Hao Q, Hu X, Xie L, Chen J, Jiang J, Dong B, et al. Prevalence of sarcopenia and associated factors in hospitalised older patients: A cross-sectional study. Australas J Ageing. 2018;37(1):62-67. doi: https://doi.org/10.1111/ajag.12492.

Bianchi L, Volpato S. Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence. Acta Diabetol. 2016;53(6):879-89. doi: https://doi.org/10.1007/s00592-016-0880-y.

Du Y, Wolf IK, KNOPF H. Association of psychotropic drug use with falls among older adults in Germany. Results of the German Health Interview and Examination Survey for Adults 2008-2011 (DEGS1). PLoS One. 2017;12(8):e0182432. doi: https://doi.org/10.1371/journal.pone.0182432.

Sarodnik C, Bours SPG, Schaper NC, van den Bergh JP, van Geel TACM. The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus. Maturitas. 2018;109:70-77. doi: https://doi.org/10.1016/j.maturitas.2017.12.011.

Published

2020-12-11

Issue

Section

Original Articles

How to Cite

1.
Torres MR dos S, Oliveira LB de, Peixoto MI. Association between sarcopenia and history of fractures in elderly patients with type 2 diabetes. Medicina (Ribeirão Preto) [Internet]. 2020 Dec. 11 [cited 2024 May 17];53(4):389-97. Available from: https://www.periodicos.usp.br/rmrp/article/view/164728